$1.73 0.11 (+6.79%)
2/13/2012 4:04 PM

K V Pharmaceutical Co. Class A (NYSE:KV-A)

CAPS Rating: 2 out of 5

Develops advanced drug delivery technologies which enhance the effectiveness of new therapeutic agents, existing pharmaceutical products and prescription nutritional products.

Recs

1
Player Avatar jesterjohn (49.82) Submitted: 3/8/2007 5:04:58 PM : Outperform Start Price: $24.27 KV-A Score: -63.73

Expect EPS comps to look very good, and chart looks like it is ready for a run-up after fairly tight price range lt

Report this Post Add Comment

Featured Broker Partners


Advertisement